Targeting Lipoxygenases (LOs): Drug Design And Discovery

E-ISSN： 1875-6662|9|2|89-105

ISSN： 1573-4080

Source： Current Enzyme Inhibition, Vol.9, Iss.2, 2013-09, pp. : 89-105

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Lipoxygenases - A Challenging Problem in Enzyme Inhibition and Drug Development

Current Enzyme Inhibition, Vol. 3, Iss. 2, 2007-05 ,pp. : 119-132

Bentham Science Publishers

Access to resources Recommend Favorite

Lipoxygenases (LOs): An Heterogenous Family of Lipid Peroxidizing Enzymes Implicated in Cell Differentiation, Inflammation, Asthma, Carcinogenesis, Atherogenesis-An Interesting Target for the Development of Promising Drugs

Current Enzyme Inhibition, Vol. 1, Iss. 3, 2005-11 ,pp. : 309-327

Bentham Science Publishers

Access to resources Recommend Favorite

Evaluating Protein-protein Interaction (PPI) Networks for Diseases Pathway, Target Discovery, and Drug-design Using ‘In silico Pharmacology’

Current Protein and Peptide Science, Vol. 15, Iss. 6, 2014-09 ,pp. : 561-571

Bentham Science Publishers

Access to resources Recommend Favorite

Structure-based Drug Design Targeting Biosynthesis of Isoprenoids: A Crystallographic State of the Art of the Involved Enzymes

Current Protein and Peptide Science, Vol. 9, Iss. 2, 2008-04 ,pp. : 117-137

Bentham Science Publishers

Access to resources Recommend Favorite

Drug discovery for inflammatory diseases

By Rogatsky Inez

Expert Opinion on Biological Therapy, Vol. 3, Iss. 6, 2003-09 ,pp. : 1001-1004

Informa Healthcare

Access to resources Recommend Favorite